HIV drug resistance mutations in non-B subtypes after prolonged virological failure on NNRTI-based first-line regimens in sub-Saharan Africa
<p>Objective: To determine drug resistance mutation (DRM) patterns in a large cohort of patients failing non-nucleoside-reverse-transcriptase-inhibitor (NNRTI)-based first-line antiretroviral therapy (ART) regimens in programmes without routine viral load (VL) monitoring and to examine inter-s...
Main Authors: | Kityo, C, Thompson, J, Nankya, I, Hoppe, A, Ndashimye, E, Warambwa, C, Mambule, I, van Oosterhout, J, Wools-Kaloustian, K, Bertagnolio, S, Easterbrook, P, Mugyenyi, P, Walker, A, Paton, N, For the Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST)Trial Team |
---|---|
Format: | Journal article |
Published: |
Lippincott, Williams & Wilkins
2017
|
Similar Items
-
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial
by: Paton, N, et al.
Published: (2017) -
NNRTI-associated mutations in patients with virologic failure on first-line regimen in Yekaterinburg
by: A. Chuykov, et al.
Published: (2014-04-01) -
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
by: Phasomsap Chayapa, et al.
Published: (2011-10-01) -
High Prevalence of Doravirine Resistance in HIV-1-Infected Patients with Virological Failure to an NNRTI-Based Single-Tablet Regimen
by: Tsai HC, et al.
Published: (2022-07-01) -
Early virological suppression despite high frequency NNRTI resistance following perinatal prophylaxis in HIV-infected African infants
by: Coovadia Hoosen, et al.
Published: (2008-04-01)